相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A review of glioblastoma immunotherapy
Ravi Medikonda et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
Navigating CAR-T cells through the solid-tumour microenvironment
Andrew J. Hou et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
IL-6 trans-signaling promotes the expansion and anti-tumor activity of CAR T cells
Zhiwu Jiang et al.
LEUKEMIA (2021)
Vessel co-option in glioblastoma: emerging insights and opportunities
Giorgio Seano et al.
ANGIOGENESIS (2020)
Targeting GD2-positive glioblastoma by chimeric antigen receptor empowered mesenchymal progenitors
Giulia Golinelli et al.
CANCER GENE THERAPY (2020)
Potential of Glioblastoma-Targeted Chimeric Antigen Receptor (CAR) T-Cell Therapy
Ryan D. Salinas et al.
CNS DRUGS (2020)
Chlorotoxin-directed CAR T cells for specific and effective targeting of glioblastoma
Dongrui Wang et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Design and Characterization of an All-in-One Lentiviral Vector System Combining Constitutive Anti-GD2 CAR Expression and Inducible Cytokines
Katharina Zimmermann et al.
CANCERS (2020)
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology (vol 9, 7154, 2019)
Olivia Candini et al.
SCIENTIFIC REPORTS (2020)
The future of cancer immunotherapy: microenvironment-targeting combinations
Yonina R. Murciano-Goroff et al.
CELL RESEARCH (2020)
CD137/CD137 ligand signalling regulates the immune balance: A potential target for novel immunotherapy of autoimmune diseases
Hiu Yi Wong et al.
JOURNAL OF AUTOIMMUNITY (2020)
Anti-GD2 CAR-NKT cells in patients with relapsed or refractory neuroblastoma: an interim analysis
Andras Heczey et al.
NATURE MEDICINE (2020)
Intravital imaging reveals synergistic effect of CAR T-cells and radiation therapy in a preclinical immunocompetent glioblastoma model
Surya Murty et al.
ONCOIMMUNOLOGY (2020)
Killing Mechanisms of Chimeric Antigen Receptor (CAR) T Cells
Mohamed-Reda Benmebarek et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor-transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma
Stephanie L. Goff et al.
JOURNAL OF IMMUNOTHERAPY (2019)
A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology
Olivia Candini et al.
SCIENTIFIC REPORTS (2019)
Clinical lessons learned from the first leg of the CAR T cell journey
Robbie G. Majzner et al.
NATURE MEDICINE (2019)
Immunotherapy for Glioblastoma: Adoptive T-cell Strategies
Bryan D. Choi et al.
CLINICAL CANCER RESEARCH (2019)
CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors
Robbie G. Majzner et al.
CLINICAL CANCER RESEARCH (2019)
High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model
Sarah A. Richman et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Brain Tumors
J. Ricardo McFaline-Figueroa et al.
AMERICAN JOURNAL OF MEDICINE (2018)
How immunotherapies are targeting the glioblastoma immune environment
Jonathan Felthun et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2018)
Optimization of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells for Improved Anti-tumor Efficacy against Glioblastoma
Christine E. Brown et al.
MOLECULAR THERAPY (2018)
Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas
Christopher W. Mount et al.
NATURE MEDICINE (2018)
The role of interleukin-6-STAT3 signalling in glioblastoma
Alice J. West et al.
ONCOLOGY LETTERS (2018)
Cancer Cells Exploit Notch Signaling to Redefine a Supportive Cytokine Milieu
Michela Colombo et al.
FRONTIERS IN IMMUNOLOGY (2018)
CART Immunotherapy: Development Success, and Translation to Malignant Gliomas and Other Solid Tumors
Anna C. Filley et al.
FRONTIERS IN ONCOLOGY (2018)
CART-Cell Therapies in Glioblastoma: A First Look
Denis Migliorini et al.
CLINICAL CANCER RESEARCH (2018)
Chimeric antigen receptors for treatment of glioblastoma: a practical review of challenges and ways to overcome them
S. Sengupta et al.
CANCER GENE THERAPY (2017)
Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy
Cristina Maccalli et al.
IMMUNOLOGICAL INVESTIGATIONS (2017)
Novel model of orthotopic U-87 MG glioblastoma resection in athymic nude mice
John Bianco et al.
JOURNAL OF NEUROSCIENCE METHODS (2017)
A single dose of peripherally infused EGFRvIII-directed CAR T cells mediates antigen loss and induces adaptive resistance in patients with recurrent glioblastoma
Donald M. O'Rourke et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
HER2-Specific Chimeric Antigen Receptor-Modified Virus-Specific T Cells for Progressive Glioblastoma A Phase 1 Dose-Escalation Trial
Nabil Ahmed et al.
JAMA ONCOLOGY (2017)
Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy
Christine E. Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Bioactivity and Safety of IL13Rα2-Redirected Chimeric Antigen Receptor CD8+ T Cells in Patients with Recurrent Glioblastoma
Christine E. Brown et al.
CLINICAL CANCER RESEARCH (2015)
A novel anti-GD2/4-1BB chimeric antigen receptor triggers neuroblastoma cell killing
Malvina Prapa et al.
ONCOTARGET (2015)
Isolation and Culture of Primary Glioblastoma Cells from Human Tumor Specimens
Sascha Seidel et al.
STEM CELL PROTOCOLS (2015)
Ganglioside GD2 in reception and transduction of cell death signal in tumor cells
Igor I. Doronin et al.
BMC CANCER (2014)
EANO guideline for the diagnosis and treatment of anaplastic gliomas and glioblastoma
Michael Weller et al.
LANCET ONCOLOGY (2014)
Recognition of Glioma Stem Cells by Genetically Modified T Cells Targeting EGFRvIII and Development of Adoptive Cell Therapy for Glioma
Richard A. Morgan et al.
HUMAN GENE THERAPY (2012)
T Cells with Chimeric Antigen Receptors Have Potent Antitumor Effects and Can Establish Memory in Patients with Advanced Leukemia
Michael Kalos et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors
Nabil Ahmed et al.
CLINICAL CANCER RESEARCH (2010)
Specific recognition and killing of glioblastoma multiforme by interleukin 13-zetakine redirected cytolytic T cells
KS Kahlon et al.
CANCER RESEARCH (2004)
分享论文
